Cistron Biotechnology Inc sales and marketing update

Sales of lymphokine assay kits rose to $264,774 in the first quarter ended Sept. 30 from $244,261 in the period last year. Net income was $12,408 (less than 1 cent per share) vs. a net loss of $19,886...